🔎 Trials Near Me

Home › Heart Failure › Indiana › South Bend

Heart Failure clinical trials in South Bend, IN

5 studies for Heart Failure are looking for participants at sites in and around South Bend (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

RecruitingPhase 3
  • Research Site, Elkhart · 14 mi away
Ages 18 to 130 · All sexes · Updated Oct 2, 2026 · NCT06307652

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

RecruitingPhase 3
  • Midwest Cardiovascular Research and Education Foundation, Elkhart · 14 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

RecruitingPhase 3
  • Midwest Cardiovascular Research and Education Foundation, Elkhart · 14 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06424288

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

RecruitingPhase 3
  • Midwest Cardiovascular Research And Education Foundation, Elkhart · 14 mi away
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

RecruitingPhase 3
  • Research Site, South Bend
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060

About Heart Failure

Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.

More about Heart Failure on MedlinePlus

Heart Failure trials in other cities

Other studies in South Bend

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.